top of page
Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
OVC481
Ovary cancer tissue array, 16 cases, 48 cores, non-over lapping with OVC241, one normal ovary tissue core paired with two tumor tissue cores from each patient, with grading and TNM staging data.
Price per slide:
$246
Species:
Human
Cases:
16
Cores:
48
Core Size:
2.0mm
Core Thickness:
4um
Rows:
6
Columns:
8
Format:
Intended Usage:
For research use only. Designed for normal vs cancer IHC or ISH based protein or RNA tissue profiling in ovary cancers.
6
X
8
For illustration purpose only. Actual product may vary.
Notes:
All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.
Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | NATURE | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|---|
A01 |  | F | 36 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
A02 |  | F | 61 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N1M0 |
A03 |  | F | 38 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
A04 |  | F | 49 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T1N0M0 |
A05 |  | F | 75 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
A06 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
A07 |  | F | 72 | Ovary | Serous cystadenocarcinoma | Malignant | I | T2N0M0 |
A08 |  | F | 69 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |
B01 |  | F | 36 | Ovary | Serous cystadenocarcinoma | Malignant | I | T1N0M0 |
B02 |  | F | 61 | Ovary | Serous cystadenocarcinoma | Malignant | II | T1N1M0 |
B03 |  | F | 38 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T3N0M1 |
B04 |  | F | 49 | Ovary | Serous cystadenocarcinoma | Malignant | II~III | T1N0M0 |
B05 |  | F | 75 | Ovary | Serous cystadenocarcinoma | Malignant | III | T3N0M0 |
B06 |  | F | 56 | Ovary | Serous cystadenocarcinoma | Malignant | III | T1N0M0 |